drugset / Trial / NCT04647357
A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer
Phase 2
Unknown
60 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
NaSingle-groupOpen-labelTreatment
Summary
SHR-1316 as Maintenance therapy for limited stage small cell lung cancer without progression after first line platinum based concurrent chemoradiotherapy
Timeline
- Start
- 2020-11-27
- Primary completion
- 2023-05-27
- Completion
- 2023-12-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adebrelimab | Monoclonal antibody | — | — |